ReviewInfection and drug resistance2026

Real-World Evidence and Multidrug Resistant Infections: How Can We Leverage RWE to Improve Patient Outcome with the Novel Beta-Lactam and Beta-Lactam/Beta-Lactamase Inhibitor Combinations.

Milo Gatti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.